Viral Vector Drug Development

 


As an end-to-end viral vector CDMO service platform,This platform can provide customers with viral vectors from process and analytical development to clinical and commercial supply, including adenovirus (Adv), lentivirus (LV), adeno-associated virus (AAV), vaccinia virus ( VACV), measles virus (MV), herpes simplex virus (HSV), vesicular stomatitis virus (VSV), reovirus (Reovirus) and other viral vectors.


Service Advantage


· The technical team of this platform has completed the construction of several adenovirus vector drugs, has rich project experience, and has a patent for the drug structure of chimpanzee AdC68 adenovirus vector (patent number: ZL201310362921.8).

· Has a quality management system and a professional quality management team that runs through the entire life cycle of the project, and conducts strict quality control of the project.

· Perfect customer service system, technical support, project follow-up, and after-sales service have won unanimous praise from customers, and are committed to providing customers with high-quality, reliable and fast technical services.